Page last updated: 2024-08-26

droxidopa and Degenerative Diseases, Central Nervous System

droxidopa has been researched along with Degenerative Diseases, Central Nervous System in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Otero-Losada, M; PĂ©rez-Lloret, S; Quarracino, C; Rascol, O1
Freeman, R; Goldstein, DS; Holmes, C; Kaufmann, H; Nardin, R; Saadia, D; Voustianiouk, A; Yahr, MD1

Reviews

1 review(s) available for droxidopa and Degenerative Diseases, Central Nervous System

ArticleYear
Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases.
    Expert opinion on pharmacotherapy, 2019, Volume: 20, Issue:6

    Topics: Amyloid Neuropathies, Familial; Blood Pressure; Droxidopa; Humans; Hypotension, Orthostatic; Japan; Neurodegenerative Diseases; Parkinson Disease; Renal Dialysis; Surveys and Questionnaires

2019

Trials

1 trial(s) available for droxidopa and Degenerative Diseases, Central Nervous System

ArticleYear
Norepinephrine precursor therapy in neurogenic orthostatic hypotension.
    Circulation, 2003, Aug-12, Volume: 108, Issue:6

    Topics: Administration, Oral; Aged; Antiparkinson Agents; Aromatic-L-Amino-Acid Decarboxylases; Blood Pressure; Carbidopa; Cross-Over Studies; Double-Blind Method; Droxidopa; Female; Hemodynamics; Humans; Hypotension, Orthostatic; Male; Middle Aged; Neurodegenerative Diseases; Norepinephrine; Posture; Single-Blind Method; Treatment Outcome

2003